PRESS RELEASE published on 03/22/2024 at 07:01, 2 years 1 month ago Evolva Holding in liquidation SA publishes liquidation interim financial statements and agenda for 2024 annual general meeting; reports positive purchase price adjustment of CHF 1,929,000 under SPA; g Evolva Holding SA in liquidation publishes liquidation interim financial statements and agenda for 2024 annual general meeting; reports a positive purchase price adjustment of CHF 1,929,000 under SPA Liquidation Evolva Holding SA AGM 2024 Purchase Price Adjustment Interim Financial Statements
BRIEF published on 03/07/2024 at 07:05, 2 years 1 month ago Evolva Holding SA Receives Agenda Requests from Major Shareholder for Upcoming AGM AGM Evolva Holding SA Nice & Green SA Shareholder Requests Reverse Takeovers
PRESS RELEASE published on 03/07/2024 at 07:00, 2 years 1 month ago Evolva Holding SA in liquidation: Nice & Green requests 3 agenda items be included in AGM agenda Evolva Holding SA in liquidation receives requests for 3 agenda items at AGM from shareholder Nice & Green SA; shareholder Pegasus Global Opportunity Fund Ltd crosses 10% threshold Shareholders AGM Evolva Holding SA Nice & Green SA Pegasus Global Opportunity Fund Ltd
PRESS RELEASE published on 09/28/2023 at 07:00, 2 years 7 months ago Evolva and LEHVOSS sign agreement for distribution of Veri-teTM Resveratrol in over a dozen European countries
PRESS RELEASE published on 09/13/2023 at 07:00, 2 years 7 months ago Evolva and Nice & Green agree on improvements to financing agreement
PRESS RELEASE published on 09/06/2023 at 07:00, 2 years 7 months ago Evolva receives approval for Veri-teTM Resveratrol in Thailand
PRESS RELEASE published on 08/24/2023 at 20:00, 2 years 8 months ago Evolva shareholders approve increase of the conditional capital and upper limit of capital band at extraordinary general meeting of 24 August 2023
PRESS RELEASE published on 08/24/2023 at 07:00, 2 years 8 months ago Evolva with good business momentum and significant progress in profitability in 1H 2023, despite major financing challenges
PRESS RELEASE published on 07/28/2023 at 07:00, 2 years 9 months ago Evolva Holding SA: Evolva convenes extraordinary general meeting (EGM) for 24 August 2023 to secure financing until end of the year
PRESS RELEASE published on 07/25/2023 at 07:00, 2 years 9 months ago Evolva receives approval for Veri-teTM Resveratrol in Taiwan
Published on 05/02/2026 at 01:30, 2 hours 30 minutes ago Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 3 hours 10 minutes ago CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 4 hours ago Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 4 hours ago Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/01/2026 at 22:30, 5 hours 30 minutes ago Nextech3D.ai Appoints New Independent Auditor
Published on 05/01/2026 at 19:23, 8 hours 37 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 17:45, 10 hours 15 minutes ago Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)
Published on 05/01/2026 at 17:21, 10 hours 38 minutes ago Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares
Published on 04/30/2026 at 20:00, 1 day 7 hours ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 1 day 8 hours ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 1 day 9 hours ago Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 1 day 9 hours ago Minutes of the Combined General Meeting held on April 30, 2026
